Emergency Contraception in Estonia

July 2013 | 16 pages | ID: E27745005C9EN
Euromonitor International Ltd

Abstracts

Emergency contraception is often used if the use of ordinary contraception is overlooked or fails for some reason. Women perceive emergency contraception as an essential means of avoiding unwanted pregnancies. In 2012, consumers in Estonia could still choose from only two brands: Escapelle and Postinor. Due to ongoing economic uncertainty, in Estonia and the wider EU, women continued to purchase emergency contraception as a precaution.

Euromonitor International's Emergency Contraception in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Emergency Contraception Company Shares 2008-2012
  Table 4 Emergency Contraception Brand Shares 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Executive Summary
Consumer Health Sales Continue To Recover in 2012
Consumers Focus More on Trusted Brands
Competition Remains Tough Due To the Spread of Private Label
Chemists/pharmacies Dominates Consumer Health in Estonia
the Economy Impacts Consumer Patterns
Key Trends and Developments
Economic Growth Shifts From Exports To Internal Consumption in 2012
Debate on Low Competition in Chemists/pharmacies
the Ageing Population Trend Positively Impacts Consumer Health
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicines
Switches
Summary 1 OTC Healthcare Switches 2010-2012
Sources
Summary 2 Research Sources